Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite Instability-High/Mismatch Repair Deficiency Metastatic Colorectal Cancer: Indirect Treatment Comparison and Cost-Effectiveness Analysis.

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Keytruda (pembrolizumab) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42709325

Bodille P M Blomaard; Claire L Simons; Craig Bennison; Elizabeth A Sigworth; Katharina Nickel; Kiran Dave; Lixian Jin; Lytske J Bakker; Reginald Villacorta; Zoe Cheah

Sep 9, 2026